Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
Quest Diagnostics
MedTech
Quest Diagnostics taps MD Anderson for cancer risk blood test
Dubbed the multi-cancer stratification test, or MCaST, Quest said it may help identify people who could benefit from more frequent screenings.
Conor Hale
Jun 10, 2025 2:11pm
Quest Diagnostics teams up with Google Cloud on gen AI
Mar 18, 2025 2:00pm
Quest Diagnostics to claim Fresenius’ dialysis testing portfolio
Feb 26, 2025 11:00am
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
Aug 21, 2024 11:00am
Quest Diagnostics carves out PathAI's digital pathology lab
May 1, 2024 10:30am
Labcorp, Quest add new blood tests for Alzheimer's, brain damage
Apr 22, 2024 2:17pm
